Targeting MYCN-amplified Neuroblastoma Through RORalpha Activation |
Baylor College of Medicine / Eveline Barbiere, MD |
Innovation Grants |
2016 |
Texas |
Combining Oncolytic Vaccinia Virus with GD2.CAR-modified Vaccinia Virus-specific T-cells for the Treatment of Relapsed Neuroblastoma and Sarcoma |
Baylor College of Medicine / Cliona Rooney, PhD |
Reach Grants |
2013 |
Texas |
Synthetic gene expression regulator switches (SynGERS) expressed in CAR T cells to cure children with solid tumors |
Baylor College of Medicine / Andras Heczey, MD |
R Accelerated Award Grants |
2023 |
Texas |
V alpha-invariant NKT cells as a novel platform for cancer immunotherapy |
Baylor College of Medicine / Leonid Metelitsa, MD, PhD |
Innovation Grants |
2012 |
Texas |
Parallel sequencing to identify the causes of childhood cancer
|
Baylor College of Medicine / Sharon Plon |
Innovation Grants |
2008 |
Texas |
Immunotherapy of Neuroblastoma with CAR.GD2 NKT Cells |
Baylor College of Medicine / Leonid S. Metelitsa, M.D., Ph.D. |
Bio-Therapeutic Impact Award |
2014 |
Texas |
Adoptive immunotherapy using clinical-grade T cells.
|
University of Texas M.D. Anderson Cancer Center / Laurence Cooper, MD, PhD |
Innovation Grants |
2007 |
Texas |
Enhancing the Viability, Function, and Safety, of Genetically-Enhanced NK Cells Within the Solid Tumor Microenvironment With IL-15 and a Suicide Gene |
Baylor College of Medicine / Robin Parihar, MD, PhD |
Young Investigator Grants |
2015 |
Texas |
The Meaning of Adolescents' Eating Experiences during Bone Marrow Transplant Recovery.
|
Baylor College of Medicine / Cheryl Rodgers, PhD, RN |
Nurse Researcher Grants |
2007 |
Texas |
Immunotherapy Of Neuroblastoma With Natural Killer T Cells Engineered To Target O-acetyl-GD2 |
Baylor College of Medicine / Andras Heczey, MD |
Young Investigator Grants |
2014 |
Texas |